Hydrocodone for cough in advanced cancer
Identifieur interne : 00A671 ( Main/Exploration ); précédent : 00A670; suivant : 00A672Hydrocodone for cough in advanced cancer
Auteurs : Jade Homsi [États-Unis] ; Declan Walsh [États-Unis] ; Kristine A. Nelson [États-Unis] ; Susan B. Legrand [États-Unis] ; Mellar Davis [États-Unis]Source :
- American Journal of Hospice and Palliative Medicine [ 1049-9091 ] ; 2000-09.
Abstract
Cough is a common symptom in advanced cancer. Hydrocodone is the antitussive of choice in our palliative medicine inpatient unit. We reviewed the pharmacy records for the use of hydrocodone for all cancer admissions to our unit from May 1996 to December 1998. Median treatment duration with hydrocodone was three days (range 1-18). Median maximum daily dose was 15 mg (range 5-100), and median total dose during the hospital stay was 32 mg (range 5-455). Lung cancer as a primary cancer site was strongly related to the use of hydrocodone. The highest median duration of treatment (five days) was for esophageal cancer and the highest median maximum daily dose (35 mg) and total dose (75 mg) were for treating kidney cancer. This retrospective review provides information regarding the use of hydrocodone on the palliative medicine unit of the Cleveland Clinic Foundation. Controlled trials are needed to evaluate the efficacy and safety of hydrocodone for cough in advanced cancer.
Url:
DOI: 10.1177/104990910001700512
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001A29
- to stream Istex, to step Curation: 001A29
- to stream Istex, to step Checkpoint: 003191
- to stream Main, to step Merge: 00AC08
- to stream Main, to step Curation: 00A671
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydrocodone for cough in advanced cancer</title><author wicri:is="90%"><name sortKey="Homsi, Jade" sort="Homsi, Jade" uniqKey="Homsi J" first="Jade" last="Homsi">Jade Homsi</name></author><author wicri:is="90%"><name sortKey="Walsh, Declan" sort="Walsh, Declan" uniqKey="Walsh D" first="Declan" last="Walsh">Declan Walsh</name></author><author wicri:is="90%"><name sortKey="Nelson, Kristine A" sort="Nelson, Kristine A" uniqKey="Nelson K" first="Kristine A." last="Nelson">Kristine A. Nelson</name></author><author wicri:is="90%"><name sortKey="Legrand, Susan B" sort="Legrand, Susan B" uniqKey="Legrand S" first="Susan B." last="Legrand">Susan B. Legrand</name></author><author wicri:is="90%"><name sortKey="Davis, Mellar" sort="Davis, Mellar" uniqKey="Davis M" first="Mellar" last="Davis">Mellar Davis</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:390695A7F92E884584279F67139A5D24478CE955</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1177/104990910001700512</idno><idno type="url">https://api.istex.fr/document/390695A7F92E884584279F67139A5D24478CE955/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001A29</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A29</idno><idno type="wicri:Area/Istex/Curation">001A29</idno><idno type="wicri:Area/Istex/Checkpoint">003191</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003191</idno><idno type="wicri:doubleKey">1049-9091:2000:Homsi J:hydrocodone:for:cough</idno><idno type="wicri:Area/Main/Merge">00AC08</idno><idno type="wicri:Area/Main/Curation">00A671</idno><idno type="wicri:Area/Main/Exploration">00A671</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Hydrocodone for cough in advanced cancer</title><author wicri:is="90%"><name sortKey="Homsi, Jade" sort="Homsi, Jade" uniqKey="Homsi J" first="Jade" last="Homsi">Jade Homsi</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Harry R. Horvitz Center for Palliative Medicine (a World Health Organization Demonstration Project), The Cleveland Clinic Taussig Cancer Center, Cleveland</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Walsh, Declan" sort="Walsh, Declan" uniqKey="Walsh D" first="Declan" last="Walsh">Declan Walsh</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Cleveland</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Nelson, Kristine A" sort="Nelson, Kristine A" uniqKey="Nelson K" first="Kristine A." last="Nelson">Kristine A. Nelson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Cleveland</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Legrand, Susan B" sort="Legrand, Susan B" uniqKey="Legrand S" first="Susan B." last="Legrand">Susan B. Legrand</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Cleveland</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Davis, Mellar" sort="Davis, Mellar" uniqKey="Davis M" first="Mellar" last="Davis">Mellar Davis</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Cleveland</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">American Journal of Hospice and Palliative Medicine</title><idno type="ISSN">1049-9091</idno><idno type="eISSN">1938-2715</idno><imprint><publisher>Sage Publications</publisher><pubPlace>Sage CA: Thousand Oaks, CA</pubPlace><date type="published" when="2000-09">2000-09</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="342">342</biblScope><biblScope unit="page" to="346">346</biblScope></imprint><idno type="ISSN">1049-9091</idno></series><idno type="istex">390695A7F92E884584279F67139A5D24478CE955</idno><idno type="DOI">10.1177/104990910001700512</idno><idno type="ArticleID">10.1177_104990910001700512</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1049-9091</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cough is a common symptom in advanced cancer. Hydrocodone is the antitussive of choice in our palliative medicine inpatient unit. We reviewed the pharmacy records for the use of hydrocodone for all cancer admissions to our unit from May 1996 to December 1998. Median treatment duration with hydrocodone was three days (range 1-18). Median maximum daily dose was 15 mg (range 5-100), and median total dose during the hospital stay was 32 mg (range 5-455). Lung cancer as a primary cancer site was strongly related to the use of hydrocodone. The highest median duration of treatment (five days) was for esophageal cancer and the highest median maximum daily dose (35 mg) and total dose (75 mg) were for treating kidney cancer. This retrospective review provides information regarding the use of hydrocodone on the palliative medicine unit of the Cleveland Clinic Foundation. Controlled trials are needed to evaluate the efficacy and safety of hydrocodone for cough in advanced cancer.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Ohio</li></region></list><tree><country name="États-Unis"><region name="Ohio"><name sortKey="Homsi, Jade" sort="Homsi, Jade" uniqKey="Homsi J" first="Jade" last="Homsi">Jade Homsi</name></region><name sortKey="Davis, Mellar" sort="Davis, Mellar" uniqKey="Davis M" first="Mellar" last="Davis">Mellar Davis</name><name sortKey="Legrand, Susan B" sort="Legrand, Susan B" uniqKey="Legrand S" first="Susan B." last="Legrand">Susan B. Legrand</name><name sortKey="Nelson, Kristine A" sort="Nelson, Kristine A" uniqKey="Nelson K" first="Kristine A." last="Nelson">Kristine A. Nelson</name><name sortKey="Walsh, Declan" sort="Walsh, Declan" uniqKey="Walsh D" first="Declan" last="Walsh">Declan Walsh</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A671 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A671 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:390695A7F92E884584279F67139A5D24478CE955
|texte= Hydrocodone for cough in advanced cancer
}}
| This area was generated with Dilib version V0.6.31. |  |